The Company achieved a total revenue of $13.6 million.Gross Profit Margins continue to demonstrate a solid performance with 30% growth year-over-year.SG&A achieves a significant reduction...
TORONTO, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning...
TORONTO, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning...
TORONTO, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE: 4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning...
TORONTO, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning...
Total revenue of $12.2 million demonstrates the Company's solid momentum year over year and ongoing growth in the rapidly expanding bulk sales market.Entourage made a strong impact with new...
TORONTO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning...
TORONTO, June 12, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning...
Total revenue of $16.4 million represents a 9% increase year-over-year and a 23% sequential increase from Q4 2023.Gross profit before fair value changes improved by 92% year-over-year, leading to...
TORONTO, May 14, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX: ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.005 | -33.3333333333 | 0.015 | 0.015 | 0.01 | 101271 | 0.01431185 | CS |
4 | 0 | 0 | 0.01 | 0.015 | 0.005 | 169309 | 0.01295453 | CS |
12 | 0 | 0 | 0.01 | 0.015 | 0.005 | 131512 | 0.01174333 | CS |
26 | -0.005 | -33.3333333333 | 0.015 | 0.015 | 0.005 | 100462 | 0.01247716 | CS |
52 | -0.005 | -33.3333333333 | 0.015 | 0.02 | 0.005 | 95926 | 0.01264113 | CS |
156 | -0.06 | -85.7142857143 | 0.07 | 0.135 | 0.005 | 108541 | 0.04029117 | CS |
260 | -0.28 | -96.5517241379 | 0.29 | 0.31 | 0.005 | 130777 | 0.07279253 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales